

Crémieux, Tess Cameron, Eoghan McCabe, Pippa Lamb, Jack Dreifuss, David Tisch, TJ Parker, Surprise U.S.-China Trade Deal, Trump EO on Drug Prices, New Air Force One in 2025?, Perplexity Valuation Surge
61 snips May 12, 2025
Join influential guests like Tess Cameron, a biotech analyst at RA Capital, and TJ Parker, co-founder of PillPack, as they explore the intricacies of drug pricing and the implications of recent healthcare policies. David Tisch from BoxGroup and Jack Dreifuss share insights on venture capital trends, while Pippa Lamb discusses the impact of U.S.-China trade dynamics on the tech industry. They dive into the complexities of healthcare costs, advocate for innovative pricing strategies, and ponder the future of AI in both healthcare and customer service.
AI Snips
Chapters
Transcript
Episode notes
US-China Trade Deal Impact
- The US-China trade deal reduced tariffs temporarily but did not end tensions. - CEOs seriously evaluated reshoring supply chains due to tariff risks.
Drug Pricing Complexity
- High US drug prices partly reflect rebates and complex pricing structures. - The most favored nation (MFN) strategy tries to align US prices with other nations but implementation is complex.
Generics Influence US Drug Prices
- The US mostly consumes generic drugs which affect price dynamics. - Generic drugs constitute 91% of US prescriptions, which changes typical overpayment assumptions.